Publications by authors named "Anne Loarec"

Claim this Profile
A
Anti-inflammatory cytokine profile and Jarisch-Herxheimer reaction in Leptospirosis patients: A prospective case-series study in New Caledonia.
Julie Cagliero, Anne Loarec, Julien Lebon, François Baur, Patrick Lefevre

PLoS Negl Trop Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping of cholera Priority Areas for Multisectoral Interventions (PAMIs) using the 2023 GTFCC guidance: The Kenya experience.
Catherine Kiama, Emmanuel Okunga, Catherine Makwe, Annastacia Muange, Martins Livinus, Anne Loarec

PLoS Negl Trop Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vertical transmission of hepatitis B virus in the WHO African region: a systematic review and meta-analysis.
Nicholas Riches, Marc Y R Henrion, Peter MacPherson, Camilla Hahn, Rabson Kachala, Anne Loarec

Lancet Glob Health· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
Robert Deiss, Carolina V Loreti, Ana G Gutierrez, Eudoxia Filipe, Milton Tatia, Anne Loarec

PLoS One· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C treatment program in Maputo, Mozambique, the challenge of genotypes and key populations: A 5-year retrospective analysis of routine programmatic data.
Anne Loarec, Ana Gabriela Gutierrez, Gil Muvale, Aleny Couto, Aude Nguyen

Health Sci Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiological characteristics and real-world treatment outcomes of hepatitis C among HIV/HCV co-infected patients in Myanmar: A prospective cohort study.
Thein Min Swe, Derek C Johnson, Htay Thet Mar, Phone Thit, Tobias Homan, Anne Loarec

Health Sci Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data set.
Jake R Morgan, Elizabeth Marsh, Alexandra Savinkina, Sonjelle Shilton, Shaun Shadaker, Anne Loarec

J Viral Hepat· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An intensive model of care for hepatitis C virus screening and treatment with direct-acting antivirals in people who inject drugs in Nairobi, Kenya: a model-based cost-effectiveness analysis.
Nyashadzaishe Mafirakureva, Jack Stone, Hannah Fraser, Yvonne Nzomukunda, Aron Maina, Anne Loarec

Addiction· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of mother-to-child transmission of hepatitis B virus in antenatal care and maternity services, Mozambique.
Anne Loarec, Aude Nguyen, Lucas Molfino, Mafalda Chissano, Natercia Madeira

Bull World Health Organ· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.
Robert Deiss, Carolina V Loreti, Ana G Gutierrez, Eudoxia Filipe, Milton Tatia, Anne Loarec

PLoS One· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of HIV, viral hepatitis B/C and tuberculosis and treatment outcomes among people who use drugs: Results from the implementation of the first drop-in-center in Mozambique.
Cynthia Semá Baltazar, Timothy A Kellogg, Makini Boothe, Anne Loarec, Ernesto de Abreu

Int J Drug Policy· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of screening and treatment using direct-acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan.
Nyashadzaishe Mafirakureva, Aaron G Lim, Gul Ghuttai Khalid, Khawar Aslam, Linda Campbell, Anne Loarec

J Viral Hepat· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar.
Lara K Marquez, Antoine Chaillon, Kyi Pyar Soe, Derek C Johnson, Jean-Marc Zosso, Anne Loarec

BMJ Glob Health· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey.
Emily Lynch, Gregoire Falq, Chhorvy Sun, Pharm D Tek Bunchhoeung, Helena Huerga, Anne Loarec

BMC Infect Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and cost-effectiveness of a simplified treatment model with direct-acting antivirals for chronic hepatitis C in Cambodia.
Josephine G Walker, Nyashadzaishe Mafirakureva, Momoko Iwamoto, Linda Campbell, Chamroeun San Kim, Anne Loarec

Liver Int· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis.
Aaron G Lim, Josephine G Walker, Nyashadzaishe Mafirakureva, Gul Ghuttai Khalid, Huma Qureshi, Anne Loarec

Lancet Glob Health· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients.
Olivier Bouchaud, Sophie Matheron, Anne Loarec, Jean Dupouy Camet, Patrice Bourée

BMC Infect Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset.
J Morgan Freiman, Jianing Wang, Philippa J Easterbrook, C Robert Horsburgh, Francesco Marinucci, Anne Loarec

J Hepatol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extremely low hepatitis C prevalence among HIV co-infected individuals in four countries in sub-Saharan Africa.
Anne Loarec, Valentina Carnimeo, Lucas Molfino, Walter Kizito, Winnie Muyindike

AIDS· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demonstration of the diagnostic agreement of capillary and venous blood samples, using hepatitis-C virus SD Bioline rapid test: A clinic-based study.
Chhorvy Sun, Momoko Iwamoto, Aurelie Calzia, Bun Sreng, Sokchea Yann, Anne Loarec

J Clin Virol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Field evaluation of GeneXpert (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia.
Momoko Iwamoto, Aurelie Calzia, Amelie Dublineau, François Rouet, Janin Nouhin, Anne Loarec

J Viral Hepat· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis